ContraFect (CFRX) - Management Comments

ContraFect (CFRX) – Management Comments

Jul 20, 2020 07:36 AM UPDATE: ContraFect (CFRX) Reports Up to $18.9M in Funding from CARB-X to Accelerate CF-370 Program in IND-Enabling Activities Toward Future Ph. 1 Clinical Trials
Jun 17, 2020 07:31 AM ContraFect (CFRX) Reports Publication of Exebacase Phase 2 Study Results in the Journal of Clinical Investigation
Jun 15, 2020 07:35 AM
May 26, 2020 07:31 AM
Feb 24, 2020 07:08 AM
Jan 10, 2020 07:06 AM
Dec 20, 2019 08:19 AM
Dec 18, 2019 07:11 AM
Oct 2, 2019 07:06 AM
Jun 6, 2019 07:08 AM
Mar 4, 2019 07:10 AM
Jan 17, 2019 07:07 AM
Jan 7, 2019 07:25 AM
Nov 12, 2018 07:03 AM
Sep 6, 2018 08:31 AM
Oct 5, 2017 07:02 AM
May 25, 2017 07:06 AM
Apr 19, 2017 07:05 AM
Mar 13, 2017 07:11 AM
Nov 17, 2016 07:18 AM
Jul 21, 2016 05:30 PM
Apr 1, 2016 10:18 AM
Dec 15, 2015 09:51 AM
Aug 17, 2015 07:02 AM